Real-World Safety and Effectiveness of Up to 12 Months of Tralokinumab Treatment in Adults With Atopic Dermatitis Who Discontinued Dupilumab Due to Conjunctivitis. J of Skin 2026, 10 (2), s729. https://doi.org/10.25251/1jtrf706.